3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Glioblastoma
4
Solitary Fibrous Tumor, Pleural
3
Mesothelioma, Malignant
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Lung Neoplasms
2
Gliosarcoma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uveal Melanoma
1
Thyroid cancer, Hurthle cell
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hypertension
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
cediranib
×
Clear all
No trials found.